AB-506

• Target:

  HBV|||Others

• Related Pathways:

  Microbiology/Virology|||Others

• Bioactivity:

  AB-506 is a compound that serves as an orally administered inhibitor specifically targeting the hepatitis B virus (HBV) core protein to obstruct HBV replication. It achieves this by binding to the HBV core protein, accelerating capsid assembly, and hindering the encapsidation of HBV pre-genomic RNA (pgRNA) . Consequently, AB-506 is utilized in the study of chronic hepatitis B (CHB) .

• Smiles:

  C (NC1=CC (Cl) =C (F) C=C1) (=O) C2=C3C ([C@@H] (NC (OCC=4N=CN (C) N4) =O) CC3) =C (F) C=C2

• Molecular Formula:

  C21H18ClF2N5O3

• Molecular Weight:

  461.85

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2245020-50-0